Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease

NCT07149571 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07149571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07149571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2025
Completion date
December 31, 2032
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic-associated fatty liver disease, nonalcoholic fatty liver disease